Skip to main content
. 2013 Oct 2;14:207. doi: 10.1186/1471-2369-14-207

Figure 3.

Figure 3

Donor/Recipient CMV risk profiles in patients with (grey bars) and without BK-viremia (white bars, Figure3A). Creatinine course at the time of discharge as well as 3 and 12 months after transplantation in patients with (grey bars) and without BK-viremia (white bars; Figure 3B). Only patients with complete creatinine values at all time points were included.